UnitedHealth Group Covers Shield Blood Test for Colorectal Cancer Screening
The Shield test is now available to eligible members aged 45 and older, expanding access to screening options for colorectal cancer.
Category: Colorectal
Colorectal
Latest
Colorectal
Latest
Blood Test Using Inflammatory Biomarkers Advances for Colorectal Cancer Detection
Irish researchers have secured €670,000 to clinically validate a blood-based colorectal cancer screening test using inflammatory biomarkers, aiming for launch by 2027 through a new spin-out company.
Colorectal
Latest
Fecal DNA Methylation Test Shows Promise for Colorectal Cancer Screening
A multicenter study reports that combining fecal SDC2 methylation testing with the APCS scoring system improves advanced adenoma detection and specificity in colorectal cancer screening.
Quest Diagnostics to Expand Blood-Based Colorectal Cancer Screening Access
The company is collaborating with Guardant Health to make Guardant’s Shield test available through Quest’s nationwide network of provider clients and patient service centers.
Read More
FDA OKs Cartridge-Based Companion Diagnostic Test for Colorectal Cancer
The test provides fully automated, sample-to-result testing to identify patients eligible for immunotherapy treatment.
Read More
Personalis Expands Tempus Strategic Collaboration to Bring Ultra-Sensitive Cancer Recurrence Testing to Colorectal Cancer Patients
Personalis has expanded and extended its partnership with Tempus AI to include colorectal cancer in their NeXT Personal MRD test.
Read More
Gut Zoomer Gets Upgrade, Adds Microbial and Metabolic Insights
Vibrant Wellness has enhanced its Gut Zoomer microbiome panel with expanded microbial and metabolite testing.
Read More
Colorectal Cancer Screening: Are Smartphones the Answer?
A study found that colorectal cancer screening could be boosted by using a rapid, accurate app-read smartphone FIT.
Read More
ColoHealth Blood Test Offers a Simpler First Step in Colorectal Cancer Screening
New Day Diagnostics has launched ColoHealth, a physician-mediated blood test for colorectal cancer screening.
Read More
Do Disasters Delay Early Cancer Diagnoses?
Natural disasters and the COVID-19 pandemic disrupted colorectal cancer diagnoses in Puerto Rico, leading to a rise in delayed diagnoses.
Read More
Sysmex to Distribute CRC Screening Solutions in Canada
Sysmex America will distribute Sentinel Diagnostics SENTiFIT 270 and 800 analyzers in Canada for colorectal cancer (CRC) screening.
Read More
Mainz Biomed and Quest Diagnostics Partner to Advance Colorectal Cancer Test
Mainz Biomed is collaborating with Quest Diagnostics to support the commercialization and FDA validation of a stool-based DNA test.
Read More
Genomic Testing Advances Lynch Syndrome Diagnosis and Cancer Treatment
A new study highlights the critical role of genomic testing in diagnosing Lynch syndrome and guiding treatment for inherited cancers.
Read More
Colorectal Cancer Screening Rates Improve with Home Testing Kits
Colorectal cancer screening, while highly effective, is underutilized among patients at federally qualified health centers (FQHCs).
Read More
Proscia and Owkin Partner on MSI Screening for Colorectal Cancer Using AI
Proscia and Owkin announced a partnership to integrate AI-driven MSI screening technology, expanding access to colorectal cancer diagnostics.
Read More
Stool DNA Test Shows High Accuracy in Detecting Colorectal Cancer
Multitarget stool DNA testing is a highly sensitive, non-invasive method for colorectal cancer screening, offering a colonoscopy alternative.
Read More
Colorectal Cancer Blood Tests Still Not as Effective as Colonoscopies
New blood tests for colorectal cancer screening are less invasive than colonoscopies but less effective at detecting early cancers.
Read More
FDA Approves Exact Sciences’ Non-Invasive Test for Colorectal Cancer Screening
The FDA approved Exact Sciences’ Cologuard Plus test, a stool DNA test that enhances colorectal cancer and precancerous lesion detection.
Read More